← FDA DRUG APPROVALS

FDA ANDA · ANDA213000

DIGOXIN

Sponsor: VISTAPHARM LLC

APPLICATION
ANDA213000
TYPE
ANDA
ORIGINAL APPROVAL
2019-10-04
LATEST ACTION
2019-10-04
ROUTE
ORAL
DOSAGE FORM
ELIXIR
MARKETING STATUS
Prescription

Products

DIGOXINPrescription
DIGOXIN 0.05MG/ML · ELIXIR · ORAL

Approval history

2019-10-04UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →